REFRACTORY METASTATIC

Clinical trials for REFRACTORY METASTATIC explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY METASTATIC trials appear

Sign up with your email to follow new studies for REFRACTORY METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug hope for tough anal cancer cases

Disease control Not yet recruiting

This study tests a drug called sacituzumab tirumotecan in 20 people with advanced anal or rectal cancer that has spread or cannot be removed and has not responded to prior treatments. The main goal is to see if the drug is safe and what side effects it causes. This is an early-ph…

Matched conditions: REFRACTORY METASTATIC

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 16, 2026 22:52 UTC

REFRACTORY METASTATIC

Get alerted when new REFRACTORY METASTATIC trials appear

New drug hope for tough anal cancer cases